ESMO/Youtube
Jul 4, 2025, 15:45
Why ESMO Endorses the European Commission’s Life Sciences Strategy?
ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“ESMO welcomes the European Commission’s Life Sciences Strategy—a vital step toward a stronger, Healthier Europe.
The commitment to reform the IVDR and improve the implementation of the Clinical Trials
Regulation is essential to ensure that Europe remains competitive and that patients gain timely access to Innovative Cancer Treatments.
With over 40,000 members worldwide, ESMO stands ready to support EU institutions with evidence-based expertise to help Europe become a global beacon for life sciences by 2030.
Let’s work together— oncologists, researchers, policymakers, and Patient Advocates—to make this vision a reality.”
More posts featuring ESMO.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 4, 2025, 15:45
Jul 4, 2025, 15:43
Jul 4, 2025, 15:14
Jul 4, 2025, 14:05
Jul 4, 2025, 10:23
Jul 4, 2025, 10:09
Jul 4, 2025, 09:39